Authors
Loading...
Experimental models reveal that RORγt inhibition decreases tumor growth and inflammation in lung cancer, suggesting a potential therapeutic target.
Yamada‐Hara et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: